Market Overview:
The global neurovascular devices/interventional neurology market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of neurological disorders, technological advancements in neurovascular devices, and rising demand for minimally invasive procedures. The aneurysm coiling and embolization devices segment is expected to account for the largest share of the global neurovascular devices/interventional neurology market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in this segment can be attributed to the increasing incidence of aneurysms and growing demand for minimally invasive procedures. The hospitals segment is expected to account for the largest share of the global neurovascular devices/interventional neurology market in 2018.
Product Definition:
Neurovascular devices are tools used by doctors to treat conditions affecting the blood vessels in the brain and spinal cord. These devices can include stents, balloons, and coils. Interventional neurology is a branch of medicine that uses these devices to treat conditions such as aneurysms, stroke, and other vascular problems in the brain and spine.
Aneurysm Coiling & Embolization Devices:
Aneurysm Coiling and Embolization (NCE) is a procedure used to treat aneurysms. It involves the use of coils or coiling instruments to compress the aneurysm and stop its growth, followed by injection of a chemical that causes it to shrink, usually in less than 30 minutes.
Cerebral Balloon Angioplasty & Stenting Systems:
Cerebral balloon angioplasty & stenting systems are used to treat or prevent stroke and is one of the most effective treatment for blood clots in cerebral arteries. It works by making a small incision in the patient's artery, which is then closed with a tiny valve-like device called an embolization coil. The procedure takes about 5 to 30 minutes depending on the size of the vessel and number of vessels involved.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics and ambulatory surgical units. The hospital segment dominated the overall market in terms of revenue in 2017. Hospitals are considered to be the most appropriate settings for neurovascular procedures due to several factors such as availability of highly skilled staff and advanced equipment, a large number of beds and intensive care unit (ICU) spaces that are required for these procedures. Moreover, hospitals have a dedicated team of healthcare professionals who are specialized in handling such cases which ensures high-quality treatment with minimal risk involved.
The clinics/ambulatory surgical units segment is expected to witness significant growth over the forecast period owing to increasing awareness among patients regarding their health issues coupled with rising disposable income levels across various regions including North America & Europe Asia Pacific Latin America Middle East & Africa which has resulted in increased demand for diagnostic solutions along with treatments that require less invasive surgeries compared to hospitals or emergency rooms.
Regional Analysis:
North America dominated the global market in 2017 owing to a well-established healthcare sector, high adoption of advanced technologies, and availability of highly skilled neurovascular surgeons. Moreover, increasing prevalence of neurological disorders such as stroke and brain aneurysm is expected to drive the regional market during the forecast period. For instance, according to data published by National Center for Health Statistics (NCHS), in 2016 about 695,000 people were diagnosed with new cases of stroke annually; around 175 thousand people died due to it.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure & facilities along with rising medical tourism activities in emerging economies like India & China. In addition, growing target disease population base coupled with rapidly developing economy will drive growth during same period.
Growth Factors:
- Increasing incidence of neurological disorders: The global prevalence of neurological disorders is estimated to be around 6%–8%. This number is expected to grow due to the increasing aging population and changes in lifestyle.
- Rising demand for minimally invasive procedures: There is an increasing demand for minimally invasive procedures, which can help reduce the risk of complications and improve patient outcomes. Neurovascular devices/interventional neurology offer a range of such options.
- Technological advancements: The field of neurovascular devices/interventional neurology is constantly evolving with new technologies being developed regularly. This helps improve the efficacy and safety profile of these devices/procedures.
- Growing awareness about neurovascular diseases: There is growing awareness about neurovascular diseases among both patients and healthcare professionals alike, which has led to an increase in demand for treatments using neurovascular devices/interventional neurology techniques . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurovascular Devices/Interventional Neurology Market Research Report
By Type
Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices, Neurothrombectomy Devices
By Application
Hospitals, Clinics, Ambulatory Surgical Units
By Companies
Stryker Corporation, Johnson & Johnson, Medtronic, Terumo, Penumbra, Microport Scientific Corporation, Abbott Vascular, W. L. Gore & Associates
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Neurovascular Devices/Interventional Neurology Market Report Segments:
The global Neurovascular Devices/Interventional Neurology market is segmented on the basis of:
Types
Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices, Neurothrombectomy Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Units
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker Corporation
- Johnson & Johnson
- Medtronic
- Terumo
- Penumbra
- Microport Scientific Corporation
- Abbott Vascular
- W. L. Gore & Associates
Highlights of The Neurovascular Devices/Interventional Neurology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aneurysm Coiling & Embolization Devices
- Cerebral Balloon Angioplasty & Stenting Systems
- Support Devices
- Neurothrombectomy Devices
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Units
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurovascular Devices/Interventional Neurology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neurovascular devices/interventional neurology is a specialty of neurology that focuses on the use of medical devices and procedures to treat or prevent neurological disorders. Devices used in neurovascular therapy may include stents, catheters, balloons, and other types of implants. Procedures performed in neurovascular therapy may include surgery, angiography (the use of X-rays to view the inside structure of blood vessels), and endovascular treatment (treatment using special tools inserted through an artery or vein).
Some of the key players operating in the neurovascular devices/interventional neurology market are Stryker Corporation, Johnson & Johnson, Medtronic, Terumo, Penumbra, Microport Scientific Corporation, Abbott Vascular, W. L. Gore & Associates.
The neurovascular devices/interventional neurology market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurovascular Devices/Interventional Neurology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurovascular Devices/Interventional Neurology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurovascular Devices/Interventional Neurology Market - Supply Chain
4.5. Global Neurovascular Devices/Interventional Neurology Market Forecast
4.5.1. Neurovascular Devices/Interventional Neurology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurovascular Devices/Interventional Neurology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neurovascular Devices/Interventional Neurology Market Absolute $ Opportunity
5. Global Neurovascular Devices/Interventional Neurology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Type
5.3.1. Aneurysm Coiling & Embolization Devices
5.3.2. Cerebral Balloon Angioplasty & Stenting Systems
5.3.3. Support Devices
5.3.4. Neurothrombectomy Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neurovascular Devices/Interventional Neurology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Ambulatory Surgical Units
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neurovascular Devices/Interventional Neurology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neurovascular Devices/Interventional Neurology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neurovascular Devices/Interventional Neurology Demand Share Forecast, 2019-2026
9. North America Neurovascular Devices/Interventional Neurology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgical Units
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Type
9.7.1. Aneurysm Coiling & Embolization Devices
9.7.2. Cerebral Balloon Angioplasty & Stenting Systems
9.7.3. Support Devices
9.7.4. Neurothrombectomy Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neurovascular Devices/Interventional Neurology Demand Share Forecast, 2019-2026
10. Latin America Neurovascular Devices/Interventional Neurology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical Units
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Type
10.7.1. Aneurysm Coiling & Embolization Devices
10.7.2. Cerebral Balloon Angioplasty & Stenting Systems
10.7.3. Support Devices
10.7.4. Neurothrombectomy Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neurovascular Devices/Interventional Neurology Demand Share Forecast, 2019-2026
11. Europe Neurovascular Devices/Interventional Neurology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical Units
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neurovascular Devices/Interventional Neurology Maket Size and Volume Forecast by Type
11.7.1. Aneurysm Coiling & Embolization Devices
11.7.2. Cerebral Balloon Angioplasty & Stenting Systems
11.7.3. Support Devices
11.7.4. Neurothrombectomy Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neurovascular Devices/Interventional Neurology Demand Share, 2019-2026
12. Asia Pacific Neurovascular Devices/Interventional Neurology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical Units
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Type
12.7.1. Aneurysm Coiling & Embolization Devices
12.7.2. Cerebral Balloon Angioplasty & Stenting Systems
12.7.3. Support Devices
12.7.4. Neurothrombectomy Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neurovascular Devices/Interventional Neurology Demand Share, 2019-2026
13. Middle East & Africa Neurovascular Devices/Interventional Neurology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical Units
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neurovascular Devices/Interventional Neurology Market Size and Volume Forecast by Type
13.7.1. Aneurysm Coiling & Embolization Devices
13.7.2. Cerebral Balloon Angioplasty & Stenting Systems
13.7.3. Support Devices
13.7.4. Neurothrombectomy Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neurovascular Devices/Interventional Neurology Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Neurovascular Devices/Interventional Neurology Market: Market Share Analysis
14.2. Neurovascular Devices/Interventional Neurology Distributors and Customers
14.3. Neurovascular Devices/Interventional Neurology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stryker Corporation
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Terumo
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Penumbra
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Microport Scientific Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Abbott Vascular
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. W. L. Gore & Associates
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
